Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from High Tide ( (TSE:HITI) ).
High Tide Inc. will report its fourth fiscal quarter and full-year 2025 financial and operational results after markets close on January 29, 2026, with the disclosures to be made available on SEDAR+, EDGAR and the company’s website. Management, including founder and CEO Raj Grover and CFO Mayank Mahajan, will host a webcast on January 30, 2026, to review the results and outline plans for 2026, offering investors and analysts an opportunity to gauge the company’s strategic direction and performance in the context of its expanding retail footprint and international medical cannabis distribution operations.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on TSE:HITI Stock
According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.
High Tide’s stock score is primarily influenced by its strong financial performance, particularly in revenue growth and cash flow generation. However, the bearish technical indicators and negative valuation metrics significantly weigh down the overall score. The lack of earnings call data and corporate events further limits the assessment.
To see Spark’s full report on TSE:HITI stock, click here.
More about High Tide
High Tide Inc. is a Calgary-based, community-focused cannabis enterprise with fully integrated operations spanning retail, e-commerce and medical cannabis distribution. Through its wholly owned subsidiary Canna Cabana, it operates the largest cannabis retail chain in Canada with 218 stores across five provinces and a roughly 12% domestic market share, as well as global online platforms for accessories and hemp-derived CBD. Its German subsidiary Remexian Pharma imports and wholesales medical cannabis from 19 countries, and the company has been repeatedly recognized among Canada’s fastest-growing businesses and top-performing venture issuers.
Average Trading Volume: 88,757
Technical Sentiment Signal: Hold
Current Market Cap: C$322.3M
For detailed information about HITI stock, go to TipRanks’ Stock Analysis page.